scholarly journals Renal function is associated with blood neurofilament light chain level in older adults

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Shoshin Akamine ◽  
Noriko Marutani ◽  
Daisuke Kanayama ◽  
Shiho Gotoh ◽  
Riki Maruyama ◽  
...  

AbstractNeurofilament light chain (NfL) is a novel biomarker of neurodegenerative diseases. It is detectable in the peripheral blood, allowing low-invasive assessment of early signs of neurodegeneration. The level of NfL gradually increases with age; however, what other factors affect it remains unclear. The present study examined the association between blood NfL level and renal function among healthy participants undergoing a health check (n = 43, serum NfL) and patients with diabetes mellitus (n = 188, plasma NfL). All participants were 60 years of age or older; none were diagnosed with dementia. In each group, levels of blood NfL and serum creatinine significantly correlated (coefficient r = 0.50, 0.56). These associations remained statistically significant even after adjustment for age, sex, and body mass index. These findings indicate that blood NfL level might be partially affected by renal function. We recommend measuring renal function for a more precise evaluation of neuroaxonal damage, in particular, among older adults.

Author(s):  
Wan‐Hsuan Lu ◽  
Kelly Virecoulon Giudici ◽  
Sophie Guyonnet ◽  
Geetika Aggarwal ◽  
Andrew D. Nguyen ◽  
...  

2019 ◽  
Vol 6 (6) ◽  
pp. 1134-1137 ◽  
Author(s):  
Marc Pawlitzki ◽  
Michaela Butryn ◽  
Florian Kirchner ◽  
Jacqueline Färber ◽  
Oliver Beuing ◽  
...  

Neurology ◽  
2016 ◽  
Vol 87 (11) ◽  
pp. 1076-1084 ◽  
Author(s):  
Georgina Arrambide ◽  
Carmen Espejo ◽  
Herena Eixarch ◽  
Luisa M. Villar ◽  
José C. Alvarez-Cermeño ◽  
...  

Stroke ◽  
2019 ◽  
Vol 50 (7) ◽  
pp. 1669-1675 ◽  
Author(s):  
Frederick K. Korley ◽  
Jason Goldstick ◽  
Mitra Mastali ◽  
Jennifer E. Van Eyk ◽  
William Barsan ◽  
...  

Medicine ◽  
2020 ◽  
Vol 99 (38) ◽  
pp. e22363 ◽  
Author(s):  
Wenyan Gao ◽  
Zhongshan Zhang ◽  
Xiaoling Lv ◽  
Qing Wu ◽  
Jing Yan ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Lingxiao He ◽  
John E. Morley ◽  
Geetika Aggarwal ◽  
Andrew D. Nguyen ◽  
Bruno Vellas ◽  
...  

AbstractNeurofilament light chain (NfL) has been associated with cognitive status in multiple neurodegenerative conditions. Studies about plasma NfL and cognitive decline in older adults are still limited. 504 older adults (median age 75 years) who expressed memory complaints were selected from the Multidomain Alzheimer’s Preventive Trial (MAPT) and were classified as normal cognition (NC) or mild cognitive impairment (MCI). Cognitive functions were measured as mini mental state examination (MMSE) and composite cognitive score (CCS) over a 4-year period. Plasma NfL was measured at the first or the second year of the MAPT. Mixed-effects linear models were performed to evaluate cross-sectional and longitudinal associations. In the whole population, higher plasma NfL was cross-sectionally associated with lower cognitive functions (MMSE: β =  − 0.007, 95% CI [− 0.013, − 0.001]; CCS: β =  − 0.003, 95% CI [− 0.006, − 0.001]). In adults with MCI, but not NC, higher plasma NfL was associated with lower CCS at the cross-sectional level (β =  − 0.003, 95% CI [− 0.005, − 0.0002]). The upper quartile NfL group further demonstrated more over time decline in CCS (β =  − 0.07, 95% CI [− 0.12, − 0.01]) under the MCI status. Plasma NfL can be a promising biomarker of progressive cognition decline in older adults with MCI.


Sign in / Sign up

Export Citation Format

Share Document